Simvastatin therapy reduces prooxidant–antioxidant balance and heat shock protein 60, 65, and 70 antibody titers: Results of a placebo-controlled cross-over trial

Autor:	Hassanzade-Daloee Mahdi, Azarpazhooh Mohammad-Reza, Khojasteh-Taheri Roshanak, Momenzade Akram, Rahsepar Amir-Ali, Barzegar Amini Maral, Tavallaei Shima, Ghayour-Mobarhan Majid, Sahebkar Amir-Hosein, Mouhebati Mohsen
Rok vydání:	2011
Předmět:	Antioxidant business.industry medicine.medical_treatment Clinical Biochemistry Antibody titer General Medicine Pharmacology Placebo Crossover study Simvastatin Heat shock protein Immunology medicine business medicine.drug Balance (ability)
Zdroj:	Clinical Biochemistry. 44:S179
ISSN:	0009-9120
DOI:	10.1016/j.clinbiochem.2011.08.931
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c856a9d6a70b032ed0a7d6f9a215a776 https://doi.org/10.1016/j.clinbiochem.2011.08.931 Zobrazit plný text záznamu Full Text from ScienceDirect